A new study, supported by Kappa Bioscience, confirms that vitamin K status is lower in hospitalised patients with COVID-19 and finds low vitamin K status to be predictive of higher mortality.
A new review presents vitamin K metabolism as the potential missing link between lung damage and thromboembolism, two of the most serious outcomes observed in COVID-19 patients.
Combined low vitamin D and K status are associated with increased all-cause mortality risk and possibly with cardiovascular events, according to a newly published cohort study.
New research on vitamin K suggests that it may promote eye health, thanks to the vitamin’s link to active matrix Gla protein, or MGP, an inhibitor of calcification in large arteries.
There is a strong link between poor vitamin K status and cardiovascular (CV) mortality, say researchers who warn that around a third of people may be deficient.
Children with low levels of vitamin K2 are at an increased risk of fractures, and small changes in vitamin K status can have a big effects on bone health, says a new study from Poland.
A lack of an active vitamin K- dependent protein may increase the risk of arterial calcification and stiffness, say two new studies that support the potential heart health benefits of vitamin K.
Can vitamin K slow the progression of dyslipidemia and impact diabetes risk? Researchers in Georgia think so, and the American Heart Foundation has awarded them a grant to study the hypothesis for the next two years.
A new study that applies a statistical analysis to food intake and disease prevalence data from a number of countries has concluded that vitamin K2 deficiency is as big a risk for developing heart disease as is smoking.
Increased intakes of long-chain menaquinones (vitamin K2) may reduce the risk of mortality from coronary heart disease (CHD), according to data from the European Prospective Investigation into Cancer and Nutrition (EPIC-NL) cohort.
Vitamin K2 leaders like NattoPharma and Kappa Bioscience met with others in the sector from India and east Asia in Geneva last week with the aim of developing a common quality standard.
The potential bone health benefits of vitamin K2 menaquinone-4 may be achievable at a daily dose of 600 micrograms, according to a new study from Kyowa Hakko with implications for formulations and health.
Glanbia Nutritionals, Inc., has been named the exclusive distributor in the US and Canada for NattoPharma ASA’s MenaQ7 Pure, a nature-identical synthetic vitamin K2 as menaquinone-7 (MK-7).
Many apparently healthy people may have insufficient levels of vitamin K2, says a new study, potentially increasing the risk of bone loss and also for hardening of the arteries.
Increased blood levels of vitamin K1 are associated with improved episodic memory in healthy older adults, says a new study that provides support for vitamin K and brain health.
Over the past five years, new food and beverage product launches containing vitamin K2 have nearly doubled worldwide (up 183%), according to new research from Mintel.
Low vitamin K1 levels may increases in the progression of arterial calcification, or hardening of the arteries, says a new study that may have greater implications for vitamin K2 than K1.
A new test will help bring clarity to the supply situation for vitamin K2, according the test’s originators. The test, developed by ingredient development and marketing firm Xsto Solutions and its supply partner Kappa Bioscience, fixes the ratios of cis-...
Consuming vitamin K2 in its MK-7 form is better for raising levels of the vitamin in serum than K2 in the MK-4 form, says a new study from Japan and the Netherlands.
Heart healthy functional foods – particularly dairy and butter/margarine – represent the biggest growth opportunity for natural vitamin K2, according to NattoPharma chief executive Peter Carlsson.
NattoPharma has been awarded a Canadian patent covering the use of menaquinone (vitamin K2) in foods and supplements for maintaining, optimizing, strengthening or promoting cardiovascular health.
The vitamin K market has a new entrant as Frutarom USA announced the launch of its uniK2 ingredient for use in functional foods and food supplements, following a successful launch in Europe.
New vitamin K2 player Kappa Bioscience will utilize third party tester ChromaDex’s reference standards and analytical methods after signing a global agreement.
The null findings of a randomised clinical trial of vitamin K2 and bone health do not mean the vitamin does not benefit skeletal health, say leading scientists in the field who have challenged the recent findings.
Consuming foods rich in vitamin K2 may reduce the risk of cancer, says a new study supporting the potential anti-cancer benefits of this emerging nutrient.
Current recommendations for vitamin K are not being met, placing people at increased risk of age-related diseases such as cancer and heart disease, says a new analysis.
Increased intakes of vitamin K2 from dietary sources may reduce the build up of calcium in arteries that leads to hardening of the blood vessels, says a new study.
PL Thomas is to market its vitamin K2 for use in dairy applications
in the US, following the ingredient's GRAS designation, the company
announced today.
Inactivation of a vitamin K-dependent protein may contribute to the
development of varicose veins, says a new study that highlights the
role of supplementation for improving vascular health.
Many apparently healthy people may be vitamin K deficient, says a new review, potentially increasing the risk of bone loss and also for arterial calcification.
Arterial calcification, a process of hardening of the arteries, may
be inhibited and even reversed with supplementation with high-dose
vitamin K, suggests an animal study.
Vitamin K2 derived from the fermented soy product natto has a
higher bioavailability than vitamin K1, results that may have
implications for functional food formulators.
A high-dose vitamin K supplement reduced calcium precipitates
associated with hardening of the arteries by 37 per cent in rats,
scientists from The Netherlands have reported.
The second new source of natural vitamin K2 is announced on the US
market in as many weeks, as Blue California is becomes exclusive
distributor of Vitamin K2-All Trans.
K2, the vitamin extracted from fermented natto soyfood, has been
shown to have greater levels of absorption in the blood than
commonly used vitamin K, as well as reducing several risk factors
for osteoporosis, suggest new findings.
